Larry M. Weisenthal - Concepedia

Author

Larry M. Weisenthal

Also Known As

L M Weisenthal, L. M. Weisenthal, L. Weisenthal, L.M. WEISENTHAL, L.M. Weisenthal, Larry M Weisenthal, Larry M. Weisenthal, Larry M. Weisenthal∗, Larry Weisenthal, Weisenthal, Larry Mark

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Atotech (United States)University of Michigan United States Department of Veterans Affairs California State University, Long Beach University of California, Irvine

About

Larry M. Weisenthal is an author at Atotech (United States) specializing in medicine, cancer research, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	986
2	Health Sciences	5	5	162
3	Cell Biology	4	4	416
4	Natural Sciences	2	2	58
5	Biochemistry	2	2	58

Larry M. Weisenthal

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Larry M. Weisenthal, J. A. Marsden, Patricia L. Dill, PubMed PathologyMetronomic ChemotherapyTumor BiologyOncologyAntineoplastic Drugs	1983	239
Clonogenic and nonclonogenic in vitro chemosensitivity assays. Larry M. Weisenthal, M. E. Lippman PubMed PathologyStem Cell BiologyCancer BiologyTumor BiologyClonogenic Assays	1985	204
Highly Specific Prediction of Antineoplastic Drug Resistance With an In Vitro Assay Using Suprapharmacologic Drug Exposures David H. Kern, Larry M. Weisenthal JNCI Journal of the National Cancer Institute	1990	176
Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Larry M. Weisenthal, Patricia L. Dill, N. B. Kurnick, PubMed Cell DeathPercent ViabilityToxicology TestingMetronomic ChemotherapyTumor Biology	1983	154
Delayed Hemorrhage after Percutaneous Liver Biopsy Cheryl M. Reichert, Larry M. Weisenthal, Harvey G. Klein Journal of Clinical Gastroenterology Delayed HemorrhageHepatologyMedicineLiver PhysiologySurgical Pathology	1983	58
In vitro assays in preclinical antineoplastic drug screening. Larry M. Weisenthal PubMed OncologyVitro AssaysPreclinical Drug EvaluationMedicineDrug Testing	1981	39
Characterization of human leukemia and Burkitt lymphoma cells by their acidic nuclear protein profiles. Larry M. Weisenthal, Raymond W. Ruddon PubMed Gene ReadoutHuman LeukemiasBlood CellPathologyLeukemia Cells	1972	37
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues Robert Alan Nagourney, John C. Messenger, David H. Kern, Cancer Chemotherapy and Pharmacology Ethacrynic AcidChemoprevention StrategyMedicineHuman TissuesPrimary Cultures	1990	37
Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer. Roy S. Weiner, B S Kramer, Gerald H. Clamon, Journal of Clinical Oncology Electrolyte DisorderPharmacotherapyMetronomic ChemotherapyHematological MalignancyOncology	1985	36
Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assays. Larry M. Weisenthal, D H Kern PubMed Inactive DrugsGood Medical PracticeCancer ManagementPharmacotherapyMetronomic Chemotherapy	1991	36

Page 1